Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MC4R | P32245 | 5/20 | 0.56 |
| ▸ | IL23R | Q5VWK5 | 10/20 | 0.55 |
| ▸ | CTSL | P07711 | 3/20 | 0.54 |
| ▸ | CTSS | P25774 | 3/20 | 0.54 |
| ▸ | CTSK | P43235 | 3/20 | 0.54 |
| ▸ | CTSH | P09668 | 1/20 | 0.54 |
| ▸ | KISS1R | Q969F8 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30014698 | 1.00 | MC4R (0.56) | MC4RIL23RCTSLCTSSCTSK | |
| SCHEMBL30418415 | 0.93 | MC4R (0.58) | MC4RIL23RCTSLCTSSCTSK | |
| SCHEMBL12094764 | 0.93 | MC4R (0.58) | MC4RIL23RCTSLCTSSCTSK | |
| SCHEMBL12094801 | 0.93 | MC4R (0.58) | MC4RIL23RCTSLCTSSCTSK | |
| SCHEMBL29862124 | 0.93 | KISS1R (0.58) | MC4RCTSLCTSSCTSKCTSH | |
| SCHEMBL12094797 | 0.93 | MC4R (0.58) | MC4RIL23RCTSLCTSSCTSK | |
| SCHEMBL12094757 | 0.93 | MC4R (0.58) | MC4RIL23RCTSLCTSSCTSK | |
| SCHEMBL12094755 | 0.93 | MC4R (0.58) | MC4RIL23RCTSLCTSSCTSK | |
| SCHEMBL29862470 | 0.93 | KISS1R (0.59) | MC4RKISS1R | |
| SCHEMBL31141775 | 0.93 | MC4R (0.56) | MC4RIL23RCTSLCTSSCTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115884790-A | Therapeutic combinations of drugs and methods of use thereof | 康圣博施医药有限公司 | 2023-03-31 | — | — | CN | claimed |
| CN-115884790-A | Therapeutic combinations of drugs and methods of use thereof | 康圣博施医药有限公司 | 2023-03-31 | — | — | CN | disclosed |
| CN-115590966-A | Therapeutic combinations of drugs and methods of use thereof | 康圣博施医药有限公司（US） | 2023-01-13 | — | — | CN | disclosed |
| CN-115350184-A | Therapeutic combinations of drugs and methods of use thereof | 康圣博施医药有限公司 | 2022-11-18 | — | — | CN | disclosed |
| CN-115304595-A | Therapeutic combinations of drugs and methods of use thereof | 康圣博施医药有限公司 | 2022-11-08 | — | — | CN | disclosed |